Vascugen is a regenerative medicine company engaged in the development of advanced therapies to treat incurable conditions caused by loss or degeneration of blood vessels. The company has exclusive, worldwide rights to a broad patent portfolio for its platform technology that enables the functional restoration of blood vessels in any organ or tissue, as well as rights covering related products and services for research, diagnostics, therapeutics, tissue engineering, organoid and 3D bio-printing applications. Driven by innovation and a team of scientific and clinical thought leaders, Vascugen was founded by Dr. Mervin C. Yoder, a pioneer and noted expert in the field of vascular stem cell biology.
Company Details
- Employees
- 5
- Address
- 5602 Research Park Blvd, Madison,wisconsin 53719,united States
- Industry
- Biotechnology
- Website
- vascugen.com
- Keywords
- for research.
- HQ
- Madison, Wisconsin
Vascugen Questions
Vascugen's website is vascugen.com
Vascugen's LinkedIn profile is https://www.linkedin.com/company/vascugen
Vascugen has
5 employees.
View email and phone details for 5
employees at Vascugen.
Vascugen's industry is
Biotechnology
Vascugen's top competitors are
Asclepii,
Cryostasis,
Reconstruct Bio,
Xenotherapeutics,
Pro Therapeutics,
Cytotheryx, Inc.,
Xm Therapeutics,
Neuesse Inc.,
Kenai Therapeutics,
Advanced Silicon Group.
Vascugen's categories are Biotechnology
